Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Government aims to promote over-the-counter drug sales

Gail Counsell
Wednesday 20 October 1993 18:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

THE GOVERNMENT is looking at ways to ensure that more medicines are sold over the counter rather than on prescription, the Department of Health indicated yesterday, writes Gail Counsell.

It wants to cut the time taken to process applications by drug companies that want to switch products from prescription-only to OTC sale, and is telling general practitioners, where appropriate, to ask patients to buy their own medicines rather than issue prescriptions for them.

Drug companies have traditionally concentrated on the prescription market because it offers profit margins two or three times as high as do OTC products.

Increasingly, however, the industry is looking at the OTC market to replace profits lost as governments seek to cut healthcare bills.

Jim Furniss, head of the pharmaceuticals division of the Department of Health, told a London conference yesterday: 'Self-medication is an idea whose time has come.'

Shares in Wellcome surged 11p to 786p after the company said research had shown its experimental anti-viral drug valaciclovir, known as Valtrex, was more effective against shingles than acyclovir, marketed under the brand name Zovirax.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in